Document Detail

Selective survival rescue in 15-lipoxygenase-1-deficient retinal pigment epithelial cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1.
MedLine Citation:
PMID:  19403949     Owner:  NLM     Status:  MEDLINE    
The integrity of the retinal pigment epithelial (RPE) cell is essential for the survival of rod and cone photoreceptor cells. Several stressors, including reactive oxygen species, trigger apoptotic damage in RPE cells preceded by an anti-inflammatory, pro-survival response, the formation of neuroprotectin D1 (NPD1), an oxygenation product derived from the essential omega-3 fatty acid family member docosahexaenoic acid. To define the ability of NPD1 and other endogenous novel lipid mediators in cell survival, we generated a stable knockdown human RPE (ARPE-19) cell line using short hairpin RNA to target 15-lipoxygenase-1. The 15-lipoxygenase-1-deficient cells exhibited 30% of the protein expression, and 15-lipoxygenase-2 remained unchanged, as compared with an ARPE-19 cell line control established using nonspecific short hairpin RNA transfected cells. NPD1 synthesis was stimulated by tumor necrosis factor alpha/H2O2-mediated oxidative stress in nonspecific cells (controls), whereas in silenced cells, negligible amounts of NPD1, 12(S)- and 15(S)-hydroxyeicosatetraenoic acid, and lipoxin A4 were found under these conditions. Neither control nor the deficient cells showed an increase in 15-lipoxygenase-1 protein content after 16 h of oxidative stress, suggesting that the increased activity of 15-lipoxygenase-1 is due to activation of pre-existing proteins. 15-Lipoxygenase-silenced cells also displayed an exacerbated sensitivity to oxidative stress-induced apoptosis when compared with the control cells. NPD1 selectively and potently rescued 15-lipoxygenase-silenced cells from oxidative stress-induced apoptosis. These results demonstrate that 15-lipoxygenase-1 is activated by oxidative stress in ARPE-19 cells and that NPD1 is part of an early survival signaling in RPE cells.
Jorgelina M Calandria; Victor L Marcheselli; Pranab K Mukherjee; Jasim Uddin; Jeremy W Winkler; Nicos A Petasis; Nicolas G Bazan
Related Documents :
21169429 - Autophagy deficiency promotes beta-lactam production in penicillium chrysogenum.
16796019 - Relation between both oxidative and metabolic-osmotic cell damages and initial injury s...
18683669 - Increased uptake of zinc in malignant cells is associated with enhanced activation of m...
12385779 - The role of oxidative stress in the ochratoxin a-mediated toxicity in proximal tubular ...
17765279 - Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid ...
15996779 - Fraxetin prevents rotenone-induced apoptosis by induction of endogenous glutathione in ...
21641039 - Transgenic overexpression of toxin-related ecto-adp-ribosyltransferase art2.2 sensitize...
7012899 - Analysis of flow cytometric data of irradiated cell populations.
6796639 - Differentiation within the gonads of drosophila revealed by immunofluorescence.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2009-04-29
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  284     ISSN:  0021-9258     ISO Abbreviation:  J. Biol. Chem.     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-22     Completed Date:  2009-08-06     Revised Date:  2014-09-15    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  17877-82     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apoptosis / drug effects*
Arachidonate 15-Lipoxygenase / genetics,  metabolism*
Blotting, Western
Docosahexaenoic Acids / pharmacology*
Hydrogen Peroxide / pharmacology
Immunoenzyme Techniques
Lipoxins / metabolism
Lipoxygenase Inhibitors
Oxidants / pharmacology
Oxidative Stress / drug effects*
Pigment Epithelium of Eye / cytology,  drug effects,  metabolism*
RNA, Small Interfering / pharmacology
Retina / cytology,  drug effects,  metabolism
Tumor Necrosis Factor-alpha / pharmacology
Grant Support
P20 RR016816/RR/NCRR NIH HHS; P20 RR016816/RR/NCRR NIH HHS; R01 EY005121/EY/NEI NIH HHS; R01 EY005121/EY/NEI NIH HHS
Reg. No./Substance:
0/Lipoxins; 0/Lipoxygenase Inhibitors; 0/Oxidants; 0/RNA, Small Interfering; 0/Tumor Necrosis Factor-alpha; 0/lipoxin A4; 0/protectin D1; 25167-62-8/Docosahexaenoic Acids; BBX060AN9V/Hydrogen Peroxide; EC protein, human; EC 15-Lipoxygenase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Participation of Chlorophyll b Reductase in the Initial Step of the Degradation of Light-harvesting ...
Next Document:  Plasma amino Acid responses after consumption of beverages with varying protein type.